YIL161W is a systematic open reading frame (ORF) identifier for a gene in Saccharomyces cerevisiae (budding yeast). ORFs in yeast are designated by their chromosomal location (e.g., "YIL" indicates chromosome IX, left arm) and sequential numbering. Proteins encoded by such ORFs are often studied for roles in essential cellular processes like DNA repair, metabolism, or stress response.
The antibody is not widely characterized or commercially available.
The target protein may be hypothetical or understudied.
The lack of data on YIL161W Antibody aligns with broader challenges in antibody validation highlighted in the search results:
Reproducibility Issues: Studies note that ~50% of commercial antibodies fail specificity tests, particularly for poorly characterized targets ([Source 13]).
Gene-Specific Characterization: Antibodies require rigorous validation using knockout (KO) cell lines or orthogonal assays (e.g., mass spectrometry) to confirm target specificity ([Source 13]).
For hypothetical proteins like YIL161W, generating reliable antibodies would require:
Protein Expression: Recombinant expression of the YIL161W-encoded protein.
Immunization: Using the purified protein to immunize host organisms (e.g., rabbits, llamas).
Hybridoma Screening: Isolating monoclonal antibodies with high affinity and specificity.
While YIL161W itself is not discussed, studies on yeast antibodies provide a framework for potential workflows:
| Step | Description | Example from Literature |
|---|---|---|
| Antigen Design | Recombinant protein expression in E. coli or yeast systems | Bovine antibodies used yeast display for CDR H3 diversification ([Source 7]). |
| Validation | KO strains to confirm antibody specificity | SGD uses KO strains to validate gene function ([Source 6]). |
| Application | Immunoprecipitation, Western blot, or immunofluorescence | Anti-tau antibodies tested in neurodegenerative models ([Source 3]). |
To address the absence of data on YIL161W Antibody, the following steps are proposed:
Bioinformatic Analysis: Confirm YIL161W’s protein-coding potential and homology to known proteins.
Collaborative Efforts: Partner with repositories like the Saccharomyces Genome Database (SGD) or the Yeast Resource Center to generate reagents.
Funding Initiatives: Leverage grants focused on understudied proteins (e.g., NIH’s "Illuminating the Druggable Genome" program).
Scp160p exhibits a distinctive subcellular distribution pattern that researchers should consider when designing experiments. While some diffuse signal is present in the cytosol, fluorescence microscopy studies using both anti-Scp160p antibodies and GFP-tagged Scp160p demonstrate significant signal enrichment around the nuclear envelope, which corresponds to the endoplasmic reticulum in yeast . Importantly, this localization to the endoplasmic reticulum is both RNA-dependent and microtubule-dependent . When planning your immunostaining experiments, consider using fractionation controls to validate your findings, as Scp160p partitions between soluble and membrane-bound compartments. A comprehensive experimental design should include appropriate markers for the nuclear envelope and ER to confirm colocalization patterns.
Scp160p demonstrates selective binding to specific mRNA targets rather than random association with transcripts. This specificity has been established through microarray analyses of RNAs released from affinity-isolated Scp160p-containing complexes, with results validated by quantitative RT-PCR . When investigating this selectivity, researchers should implement stringent controls comparing the bound RNA profile with total RNA from the same lysates. The specific mRNA targets identified include DHH1, YOR338W, BIK1, YOL155C, and NAM8 . This selective association has functional consequences, as loss of Scp160p results in significant changes in both abundance and subcellular distribution of target mRNAs. For example, YOR338W shows altered distribution between soluble and membrane fractions, while both DHH1 and YOR338W exhibit shifts in polyribosome association profiles .
For effective immunoprecipitation (IP) of YIL161W/Scp160p complexes, researchers have several methodological options. The classical approach uses immobilized antibodies to capture Scp160p via antigen-binding sites from cell lysates . For large-scale studies, a tagged protein approach is more efficient - either using peptide tags genetically fused to Scp160p's C/N-terminus or intact protein tags like GFP . The GFP tag approach offers the additional advantage of enabling visualization through intrinsic fluorescence. When planning your experiment, consider that Scp160p associates with both soluble and membrane-bound polyribosomes , so your lysis conditions must be optimized to maintain these associations while still solubilizing the protein effectively. RNase treatment controls are essential to determine which interactions are RNA-dependent versus direct protein-protein interactions.
Fluorobodies represent an innovative approach for studying YIL161W by combining the specificity of antibodies with the intrinsic fluorescence of GFP. This technique involves inserting diverse antibody binding loops into four exposed loops at one end of GFP, effectively mimicking the natural antibody binding footprint . For YIL161W studies, fluorobodies offer several methodological advantages: (1) simultaneous visualization and binding without secondary detection steps; (2) correlation between fluorescence intensity and binding activity, enabling rapid determination of functionality, concentration, and affinity; and (3) compatibility with multiple assay formats including ELISAs, flow cytometry, immunofluorescence, arrays, and gel shift assays .
To implement this approach, researchers should design binding loops targeting specific epitopes on YIL161W, express and purify the fluorobodies, and validate binding using purified YIL161W protein before cellular applications. When compared to standard antibodies for studying YIL161W localization, fluorobodies provide higher stability, easier expression in various systems, and improved solubility while maintaining comparable affinity and specificity .
Several computational methods can predict epitope binding for YIL161W antibodies, with SPACE2 emerging as one of the most effective approaches. This method clusters antibodies based on the structural similarity of all six CDR loops, using homology models produced by ABodyBuilder . The process involves quality filtering of structural database entries, followed by modeling CDR loops through a template database search method or hybrid homology modeling when suitable templates are unavailable .
For YIL161W antibody epitope prediction, researchers should implement the following methodology:
Generate homology models of antibodies using ABodyBuilder with quality-filtered structural database entries
Calculate root-mean-square deviation (RMSD) between CDR loops using a threshold of 1.25 Å
Perform agglomerative clustering with a "complete" linkage criterion
Validate predictions through experimental methods such as crystallography or mutation escape profiling
This computational approach achieves higher accuracy compared to sequence-based methods alone and offers researchers a valuable tool for predicting antibody-epitope interactions prior to experimental validation .
Active learning strategies can significantly enhance the efficiency of YIL161W antibody binding prediction in library-on-library screening approaches. This methodology begins with a small labeled subset of data and iteratively expands the dataset to optimize experimental resource allocation . For researchers studying YIL161W antibody binding, implementing active learning can reduce the number of required antigen mutant variants by up to 35% compared to random sampling approaches .
The implementation process involves:
Creating an initial small training dataset of YIL161W antibody-antigen binding pairs
Developing a machine learning model to predict binding based on this initial dataset
Using one of the three top-performing algorithms to select the next most informative samples for experimental testing
Iteratively updating the model with new experimental data
This approach is particularly valuable for out-of-distribution prediction scenarios, where test antibodies and antigens are not represented in the training data . When properly implemented, active learning can accelerate the discovery process by up to 28 experimental iterations compared to random sampling approaches, resulting in significant time and resource savings .
When optimizing immunoprecipitation protocols for YIL161W/Scp160p complexes, researchers must address several critical factors:
Lysis conditions: Since Scp160p associates with both soluble and membrane-bound polyribosomes , your lysis buffer must effectively solubilize membrane components while preserving protein-protein interactions. Consider using a buffer containing 1% NP-40 or similar non-ionic detergent with protease and RNase inhibitors.
Antibody selection: For native Scp160p, use validated antibodies against specific epitopes. Alternatively, generate tagged versions (GFP, FLAG, etc.) for generic immunoprecipitation approaches . For high-throughput studies, tagged versions allow standardized protocols across multiple proteins.
Controls for specificity: Include appropriate negative controls such as IgG from the same species and lysates from Scp160p-null cells to identify non-specific binding .
RNA dependence: Since Scp160p-RNA interactions are biologically significant, perform parallel experiments with and without RNase treatment to distinguish RNA-dependent from RNA-independent interactions .
Wash stringency optimization: Balance between preserving genuine interactions and removing background. Titrate salt concentration and detergent levels to optimize signal-to-noise ratio.
Validation approach: Confirm immunoprecipitation efficiency through western blotting and validate the biological significance of interactions through polysome profiling and subcellular fractionation experiments .
To effectively study how YIL161W/Scp160p absence affects target mRNA distribution, researchers should implement a comprehensive experimental design:
Generate appropriate genetic models: Create Scp160p-null yeast strains using standard gene deletion techniques. Include complementation controls with wild-type Scp160p to confirm specificity of observed effects .
Cell fractionation methodology: Implement differential centrifugation to separate soluble and membrane-bound fractions. The protocol should include:
Polyribosome profiling: Analyze association of specific mRNAs with polyribosomes by:
Quantitative analysis: Compare the distribution profiles of target mRNAs between wild-type and Scp160p-null strains, using non-target mRNAs as controls. Calculate the percentage of each mRNA in different fractions and perform statistical analysis of replicate experiments .
Validation approaches: Confirm findings using complementary techniques such as fluorescence in situ hybridization (FISH) to visualize target mRNA localization in intact cells.
For comprehensive analysis of YIL161W/Scp160p protein interactions, researchers should consider combining multiple complementary approaches:
Affinity Purification-Mass Spectrometry (AP-MS): This represents the gold standard for high-throughput interactome analysis. For YIL161W/Scp160p:
Express tagged versions (C- or N-terminal tags considering protein functionality)
Perform pull-downs with appropriate matrices (antibody-based or direct tag affinity)
Analyze using high-sensitivity MS techniques such as timsTOF Pro mass spectrometry with PASEF technology
Implement quantitative approaches (SILAC or TMT labeling) to distinguish specific interactions from background
Proximity Labeling: Methods such as BioID or TurboID can identify proteins in close proximity to Scp160p in living cells, capturing both stable and transient interactions .
Co-fractionation approaches: Size-exclusion chromatography coupled to MS (SEC-MS) or ion-exchange chromatography (IEX-MS) can identify complexes containing Scp160p based on co-elution profiles .
Crosslinking MS (XL-MS): This approach can identify direct binding interfaces between Scp160p and its interaction partners, providing structural insights into complex formation .
Data analysis considerations:
Filter against common contaminant databases like the "CRAPome"
Apply scoring algorithms that incorporate quantitative information
Validate key interactions using orthogonal methods such as co-immunoprecipitation or yeast two-hybrid
Compare data across different methodologies to build a high-confidence interactome
This multi-method approach provides greater coverage and confidence in identified interactions than any single method alone, addressing both stable and transient interactions across different cellular compartments .